Finzati - Logo
TEVA logo

Teva Pharmaceutical Industries Limited

TEVA • Drug Manufacturers - Specialty & Generic
$36.36
▼ -0.26 (-0.71%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$41.23B
Growth
11.3%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1Consistent free cash flow · 5/5High debt level · 2.2
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$36.36
Change-0.71%
Market Cap$41.23B
52W Range14.99 - 37.35
Beta0.86
Gross Margin51.79%
Oper. Margin12.50%
Profit Margin8.17%
Debt/Eq2.20
Current Ratio1.04
Quick Ratio0.80
Revenue 5Y11.28%

Investment DNA

How strong this company looks for long-term investors

64
out of 100
Business Quality
Margins, moat, returns
65/100
Financial Strength
Debt, cash, stability
33/100
Growth Potential
Revenue and expansion
63/100
Price Attractiveness
Cheap or expensive today
63/100
Why this score▼
Positive free cash flow · 1Consistent free cash flow · 5/5High debt level · 2.2

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-31
Low
$40.00
Mean
$42.00
Median
$42.00
High
$44.00

Company Overview

IPO: 2/16/1982
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 4.53
Debt / Equity i: 2.20
Operating Margin: 12.50%
Net Margin: 8.17%
ROE i: -
ROIC: -

Financial Health

Score7 / 20
Debt / Equity: 2.20
Current Ratio: 1.04
Quick Ratio: 0.80
Status: Weak

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Shields Matthew
Transaction: 06/18/2026
SELL
Change
-9,989
Price
$32.19
Filing
06/22/2026
Type
SELL
Kalif Eliyahu Sharon
Transaction: 06/11/2026
SELL
Change
-106,563
Price
$34.10
Filing
06/16/2026
Type
SELL
Francis Richard D
Transaction: 06/05/2026
SELL
Change
-13,043
Price
Not reported
Filing
06/08/2026
Type
SELL